Simon N. Whitney, MD, JD

Associate Professor and William O'Donnell and Regina O'Donnell Chair in Family Medicine

Department of Family and Community Medicine

Associate Professor, Center for Medical Ethics and Health Policy

Baylor College of Medicine

Houston, TX

USA.

Easy to read resource on the theory and practice of IRB operations and regulations

Covers full range of IRB issues and controversies

Authored by an accomplished academic physician with deep involvement in IRB issues

Includes supplementary material: [...]

Table of Contents

Title Page

Dedication

Preface

Acknowledgements

Chapter 1. Introduction

1.1 Overview

1.2 Ethics and the IRB

1.3 IRB Process

1.4 Evaluating Biomedical Research

1.5 Consent in Biomedical Research

1.6 The Social Sciences

1.7 Biomedical Research Topics

1.8 FDA and OHRP

1.9 The Future

Chapter 2. Ethics and the IRB

2.1 Your Influential Position

2.2 Evidence

2.3 Scandal

2.4 Research Ethics

2.4.1 Two Ethical Principles

2.4.2 Two Ethical Goals

2.4.3 Goals into Practice

2.4.4 Today's Loss of Balance

2.4.5 It's Always about People

2.5 Ethical Goals and Regulatory Means

2.5.1 Principles of Regulation

2.5.2 Organization and Legal Framework

2.6 Your IRB Service

2.6.1 Compensation

2.6.2 Protection from Lawsuits

2.6.3 The Community Member

2.7 The Triumph of Ethics Review

Chapter 3. IRB Process

3.1 Principles

3.1.1 Respectfulness

3.1.2 Transparency

3.1.3 Efficiency

3.1.4 Clarity

3.1.5 Accountability

3.1.6 Judiciousness

3.1.7 Rationality

3.1.8 Restraint

3.2 The Curse of Power

3.2.1 Scope of IR

3.2.2 Litigation Prevention

3.2.3 Beyond the Regulations

Chapter 4. Evaluating Biomedical Research

4.1 The Objective IRB

4.1.1 Ramsey and the Scientist's Bias

4.1.2 Your Reasonable Understanding

4.2 Literature Reviews

4.2.1 Death at Johns Hopkins

4.2.2 Reviews by Investigators

4.2.3 Reviews by IRBs

4.3 Ethics and Science

4.3.1 Scientific Modifications

4.3.2 The Value of Research

4.3.3 Risk

4.4 Weighing Risks, Benefits, and Knowledge

4.4.1 Why You Should Protect Subjects

4.4.2 Why You Should Let Subjects Choose

4.4.3 The Conundrum

4.5 Approval Based on Risk and Benefit

4.5.1 Established Theories

4.5.2 Rajczi and Meyer: Let the Subjects Decide

4.6 Consent before Approval

Chapter 5. Consent in Biomedical Research

5.1 Consent's Goals

5.2 Multisite Consent Forms

5.3 Presenting Risk and Benefit

5.4 Subject Understanding

5.4.1 Less is More

5.4.2 Ethical Considerations

5.5 Supervising Consent Form Writing

5.5.1 Helping the Investigator

5.5.2 Readability

5.5.3 Format

5.6 Editing the Consent Form

Chapter 6. The Social Sciences

6.1 The Value of Dissent

6.2 The Social Impact of R

6.4 Psychology

6.4.1 Deception

6.4.2 Threats to Self-Esteem

6.5 Surveys and Interviews

6.5.1 Risk and Benefit

6.5.2 Modifications

6.6 Field Research

6.6.1 Risk

6.6.2 The Sociologists' Dispute

6.7 Racial Discrimination

Chapter 7. Biomedical Research Topics

7.1 Archival Research

7.1.1 Cancer of the Vagina

7.1.2 Regulatory Oversight

7.1.3 Ethical Considerations

7.1.4 The Common Rule

7.1.5 HIPAA

7.2 The Learning Health Care System

7.2.1 Integrating Research and Clinical Care

7.2.2 Ethical Considerations

7.2.3 Your IRB's Role

7.3 Randomized Controlled Trials

7.3.1 Risks Inside and Outside of a Trial

7.3.2 Nonphysical Risks

7.4 Comparative Effectiveness Trials

7.4.1 Identifying the Better Treatment

7.4.2 Faden's Bold Ethical Proposal

7.4.3 Waiver of Consent in Special Circumstances

7.5 Justice

7.5.1 Unjust Burdens

7.5.2 The Governmental Pursuit of Justice

7.5.3 The Private Pursuit of Justice

7.6 The Vulnerable

7.6.1 Regulatory Overprotection

7.6.2 Fighting Health Disparities

7.7 Paying Subjects

7.7.1 Respecting Subject Choice

7.7.2 Coercion

7.7.3

7.8 Emergency Research

7.8.1 Criteria for Approval

7.8.2 Ethical Considerations

7.9 Phase 1 Cancer Trials

Chapter 8. FDA and OHRP

8.1 Agencies under Pressure

8.2 Your IRB and the Agencies

8.2.1 Balancing Three Goals

8.2.2 When Regulations Trump Ethics

8.2.3 The Successful IRB

8.2.4 Things Can Go Wrong

8.3 Pushing Back against Federal Pressure

8.3.1 The Agency

8.3.2 The Funder

8.3.3 The Media

8.3.4 The Courts

8.4 Risk and your IRB

Chapter 9. The Future

9.1 Evidence

9.2 Reform

9.3 The Challenge

References

Index